Recent Finacing
Recent Raise
Ironshore develops and commercializes JORNAY PM, an FDA‑approved evening‑dosed extended‑release methylphenidate capsule for ADHD (ages 6+), targeting early‑morning and daytime symptom control for U.S. providers.
Focus Areas
Total Raised
Funding round
See the team members at Ironshore Pharmaceuticals.
